Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Curent Deferred Tax Liability: 2012-2014

Historic Curent Deferred Tax Liability for Ligand Pharmaceuticals (LGND) over the last 3 years, with Dec 2014 value amounting to $257,000.

  • Ligand Pharmaceuticals' Curent Deferred Tax Liability fell 83.61% to $258,000 in Q1 2015 from the same period last year, while for Mar 2015 it was $258,000, marking a year-over-year decrease of 83.61%. This contributed to the annual value of $257,000 for FY2014, which is 83.67% down from last year.
  • Latest data reveals that Ligand Pharmaceuticals reported Curent Deferred Tax Liability of $257,000 as of FY2014, which was down 83.67% from $1.6 million recorded in FY2013.
  • In the past 5 years, Ligand Pharmaceuticals' Curent Deferred Tax Liability ranged from a high of $1.6 million in FY2012 and a low of $257,000 during FY2014.
  • For the 3-year period, Ligand Pharmaceuticals' Curent Deferred Tax Liability averaged around $1.1 million, with its median value being $1.6 million (2013).
  • Data for Ligand Pharmaceuticals' Curent Deferred Tax Liability shows a maximum YoY tumbled of 83.67% (in 2014) over the last 5 years.
  • Over the past 3 years, Ligand Pharmaceuticals' Curent Deferred Tax Liability (Yearly) stood at $1.6 million in 2012, then fell by 0.44% to $1.6 million in 2013, then tumbled by 83.67% to $257,000 in 2014.